News
GNTA
1.460
-2.67%
-0.040
Maxim Group Sticks to Their Buy Rating for Genenta Science SpA Sponsored ADR (GNTA)
TipRanks · 2d ago
Weekly Report: what happened at GNTA last week (1215-1219)?
Weekly Report · 3d ago
Weekly Report: what happened at GNTA last week (1208-1212)?
Weekly Report · 12/15 10:43
Market Pulse: Tilray Leads After-Hours Rally As Biotech Peers Surge
NASDAQ · 12/15 02:51
Weekly Report: what happened at GNTA last week (1201-1205)?
Weekly Report · 12/08 10:41
Weekly Report: what happened at GNTA last week (1124-1128)?
Weekly Report · 12/01 10:36
Weekly Report: what happened at GNTA last week (1117-1121)?
Weekly Report · 11/24 10:41
Genenta Science provides update from TEM-GBM study
TipRanks · 11/24 10:10
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
Barchart · 11/24 03:00
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 11/20 21:06
Earnings Momentum Lifts PACS And Nutex; Zynex And Genenta Also Advance After Hours
NASDAQ · 11/20 04:43
Weekly Report: what happened at GNTA last week (1110-1114)?
Weekly Report · 11/17 10:42
Weekly Report: what happened at GNTA last week (1103-1107)?
Weekly Report · 11/10 10:39
Genenta Science Expands Board and Corporate Purpose Following Shareholders’ Meeting
TipRanks · 11/04 11:33
Weekly Report: what happened at GNTA last week (1027-1031)?
Weekly Report · 11/03 10:39
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 10/29 17:06
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 10/29 12:06
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/29 09:05
GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains
NASDAQ · 10/29 05:03
Genenta Science Secures $15 Million in Registered Direct Offering
TipRanks · 10/28 10:46
More
Webull provides a variety of real-time GNTA stock news. You can receive the latest news about Genenta Science Spa through multiple platforms. This information may help you make smarter investment decisions.
About GNTA
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.